CHANGING THE PARADIGM
OF MEDICINE
Microviable Therapeutics is developing a novel category of microbiota-based biotherapeutic products for gut, skin and neurological disorders. Our current strategy includes the use of live biotherapeutic products (LBPs) based on rationally design microbial communities as well as isolated&purified microbiota from validated healthy donors. We have five preclinical stage programs in development for Autism Spectrum Disorder, Crohn´s disease, Atopic Dermatitis, longevity and sports performance.
Our five preclinical stage programs and related information are disclosed below:
| Program | Indication | Data collection | Discovery | Product | Preclinical |
|---|---|---|---|---|---|
| MVT-Prj-601 | Atopic Dermatitis | ||||
| MVT-Prj-701 | Longevity | ||||
| MVT-Prj-1001 | Sports Performance | ||||
| MVT-Prj-801 | Autism Spectrum Disorder | ||||
| MVT-Prj-901 | Crohn´s disease |
Program: MVT-Prj-601
Indication: Atopic Dermatitis
Discovery Fase
Program: MVT-Prj-701
Indication: Longevity
Discovery Fase
Program: MVT-Prj-1001
Indication:Sports Performance
Data collection fase
Program: MVT-Prj-801
Indication: Autism Spectrum Disorder
Data collection fase
Program: MVT-Prj-901
Indication: Crohn´s disease
Data collection fase
Over the last four years we have built up our platform powered by innovation leading to tangible products and technologies. Microviable Therapeutics currently have one of the largest and most diverse proprietary, gut bacterial strain culture collections as well the technology to isolate and preserve viable microbiota for long-term without altering its original identity.
| Program | Concept | Technology develop. | Product | Preclinical | Clinical | Marketed |
|---|---|---|---|---|---|---|
| MVT-Prj-301 | Purified microbiota storage | |||||
| MVT-Prj-401 | Bacterial culture collection | |||||
| MVT-Prj-101 | GutAlive® |
Program: MVT-Prj-301
Indication: Purified microbiota storage
Preclinical Stage
Program: MVT-Prj-401
Indication: Bacterial culture collection
Outlicensing